Global Health Management
Management criteria checks 4/4
Global Health's CEO is Alumootil Mathew Cherian, appointed in Nov 2022, has a tenure of 2.08 years. total yearly compensation is A$346.30K, comprised of 79.1% salary and 20.9% bonuses, including company stock and options. directly owns 41.65% of the company’s shares, worth A$3.26M. The average tenure of the management team and the board of directors is 2.6 years and 7.3 years respectively.
Key information
Alumootil Mathew Cherian
Chief executive officer
AU$346.3k
Total compensation
| CEO salary percentage | 79.1% |
| CEO tenure | 2.1yrs |
| CEO ownership | 41.6% |
| Management average tenure | 2.6yrs |
| Board average tenure | 7.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$346k | AU$274k | -AU$1m |
| Mar 31 2024 | n/a | n/a | -AU$4m |
| Dec 31 2023 | n/a | n/a | -AU$6m |
| Sep 30 2023 | n/a | n/a | -AU$7m |
| Jun 30 2023 | AU$374k | AU$274k | -AU$8m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$3m |
| Sep 30 2022 | n/a | n/a | -AU$3m |
| Jun 30 2022 | AU$395k | AU$330k | -AU$2m |
| Mar 31 2022 | n/a | n/a | -AU$2m |
| Dec 31 2021 | n/a | n/a | -AU$2m |
| Sep 30 2021 | n/a | n/a | -AU$1m |
| Jun 30 2021 | AU$486k | AU$253k | -AU$488k |
| Mar 31 2021 | n/a | n/a | -AU$173k |
| Dec 31 2020 | n/a | n/a | AU$142k |
| Sep 30 2020 | n/a | n/a | -AU$29k |
| Jun 30 2020 | AU$286k | AU$212k | -AU$200k |
| Mar 31 2020 | n/a | n/a | -AU$751k |
| Dec 31 2019 | n/a | n/a | -AU$1m |
| Sep 30 2019 | n/a | n/a | -AU$1m |
| Jun 30 2019 | AU$291k | AU$222k | -AU$1m |
| Mar 31 2019 | n/a | n/a | -AU$1m |
| Dec 31 2018 | n/a | n/a | -AU$1m |
| Sep 30 2018 | n/a | n/a | -AU$2m |
| Jun 30 2018 | AU$270k | AU$213k | -AU$2m |
Compensation vs Market: Alumootil Mathew's total compensation ($USD215.24K) is about average for companies of similar size in the Australian market ($USD288.21K).
Compensation vs Earnings: Alumootil Mathew's compensation has been consistent with company performance over the past year.
CEO
Alumootil Mathew Cherian (67 yo)
2.1yrs
Tenure
AU$346,299
Compensation
Mr. Alumootil Mathew Cherian, B.Bus. (IS/IT), MACS, MAICD, had been the Chief Executive Officer and Managing Director of Global Health Ltd. (Formerly Working Systems Solutions Ltd.) since January 2002 unti...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD & Executive Director | 2.1yrs | AU$346.30k | 41.65% A$ 3.3m | |
| Chief Technology Officer | no data | AU$247.87k | 0.52% A$ 41.0k | |
| Chief Information Officer | 3.7yrs | no data | no data | |
| Vice President of Investor Relations | 3.1yrs | no data | no data | |
| Company Secretary | 1.9yrs | no data | no data |
2.6yrs
Average Tenure
Experienced Management: GLH's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Group MD & Executive Director | no data | AU$346.30k | 41.65% A$ 3.3m | |
| Independent Non-Executive Director | 23.9yrs | AU$49.95k | 0.75% A$ 58.6k | |
| Independent Non-Executive Chairman | 11.3yrs | AU$72.15k | 0.84% A$ 65.7k | |
| Independent Non-Executive Director | 3.3yrs | AU$49.95k | 0.069% A$ 5.4k | |
| Independent Non-Executive Director | 2.4yrs | AU$49.95k | 0.060% A$ 4.7k |
7.3yrs
Average Tenure
67yo
Average Age
Experienced Board: GLH's board of directors are considered experienced (7.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 19:39 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Global Health Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|